دورية أكاديمية
أعرض في EDS

A lysosomal enigma CLN5 and its significance in understanding neuronal ceroid lipofuscinosis.

التفاصيل البيبلوغرافية
العنوان: A lysosomal enigma CLN5 and its significance in understanding neuronal ceroid lipofuscinosis.
المؤلفون: Basak I; Neurodegenerative and Lysosomal Disease Laboratory, Department of Biochemistry, School of Biomedical Sciences, Brain Health Research Centre, University of Otago, 710 Cumberland Street, Dunedin, 9016, New Zealand., Wicky HE; Neurodegenerative and Lysosomal Disease Laboratory, Department of Biochemistry, School of Biomedical Sciences, Brain Health Research Centre, University of Otago, 710 Cumberland Street, Dunedin, 9016, New Zealand., McDonald KO; Neurodegenerative and Lysosomal Disease Laboratory, Department of Biochemistry, School of Biomedical Sciences, Brain Health Research Centre, University of Otago, 710 Cumberland Street, Dunedin, 9016, New Zealand., Xu JB; Neurodegenerative and Lysosomal Disease Laboratory, Department of Biochemistry, School of Biomedical Sciences, Brain Health Research Centre, University of Otago, 710 Cumberland Street, Dunedin, 9016, New Zealand., Palmer JE; Neurodegenerative and Lysosomal Disease Laboratory, Department of Biochemistry, School of Biomedical Sciences, Brain Health Research Centre, University of Otago, 710 Cumberland Street, Dunedin, 9016, New Zealand., Best HL; Neurodegenerative and Lysosomal Disease Laboratory, Department of Biochemistry, School of Biomedical Sciences, Brain Health Research Centre, University of Otago, 710 Cumberland Street, Dunedin, 9016, New Zealand.; School of Biosciences, Cardiff University, Sir Martin Evans Building, Museum Avenue, Wales, CF10 3AX, United Kingdom., Lefrancois S; Centre INRS-Institut Armand-Frappier, INRS, Laval, H7V 1B7, Canada.; Department of Anatomy and Cell Biology, McGill University, Montreal, H3A 2B2, Canada., Lee SY; Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, 66160, USA., Schoderboeck L; Neurodegenerative and Lysosomal Disease Laboratory, Department of Biochemistry, School of Biomedical Sciences, Brain Health Research Centre, University of Otago, 710 Cumberland Street, Dunedin, 9016, New Zealand., Hughes SM; Neurodegenerative and Lysosomal Disease Laboratory, Department of Biochemistry, School of Biomedical Sciences, Brain Health Research Centre, University of Otago, 710 Cumberland Street, Dunedin, 9016, New Zealand. stephanie.hughes@otago.ac.nz.
المصدر: Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2021 May; Vol. 78 (10), pp. 4735-4763. Date of Electronic Publication: 2021 Apr 01.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Springer Country of Publication: Switzerland NLM ID: 9705402 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1420-9071 (Electronic) Linking ISSN: 1420682X NLM ISO Abbreviation: Cell Mol Life Sci Subsets: MEDLINE
أسماء مطبوعة: Publication: Basel : Springer
Original Publication: Basel ; Boston : Birkhauser, c1997-
مواضيع طبية MeSH: Mutation*, Lysosomal Membrane Proteins/*genetics , Lysosomes/*metabolism , Neuronal Ceroid-Lipofuscinoses/*pathology, Animals ; Humans ; Lysosomal Membrane Proteins/metabolism ; Neuronal Ceroid-Lipofuscinoses/etiology ; Neuronal Ceroid-Lipofuscinoses/metabolism
مستخلص: Neuronal Ceroid Lipofuscinosis (NCL), also known as Batten disease, is an incurable childhood brain disease. The thirteen forms of NCL are caused by mutations in thirteen CLN genes. Mutations in one CLN gene, CLN5, cause variant late-infantile NCL, with an age of onset between 4 and 7 years. The CLN5 protein is ubiquitously expressed in the majority of tissues studied and in the brain, CLN5 shows both neuronal and glial cell expression. Mutations in CLN5 are associated with the accumulation of autofluorescent storage material in lysosomes, the recycling units of the cell, in the brain and peripheral tissues. CLN5 resides in the lysosome and its function is still elusive. Initial studies suggested CLN5 was a transmembrane protein, which was later revealed to be processed into a soluble form. Multiple glycosylation sites have been reported, which may dictate its localisation and function. CLN5 interacts with several CLN proteins, and other lysosomal proteins, making it an important candidate to understand lysosomal biology. The existing knowledge on CLN5 biology stems from studies using several model organisms, including mice, sheep, cattle, dogs, social amoeba and cell cultures. Each model organism has its advantages and limitations, making it crucial to adopt a combinatorial approach, using both human cells and model organisms, to understand CLN5 pathologies and design drug therapies. In this comprehensive review, we have summarised and critiqued existing literature on CLN5 and have discussed the missing pieces of the puzzle that need to be addressed to develop an efficient therapy for CLN5 Batten disease.
التعليقات: Erratum in: Cell Mol Life Sci. 2024 Jan 18;81(1):45. (PMID: 38236309)
References: Mol Ther. 2018 Oct 3;26(10):2366-2378. (PMID: 30078766)
J Pediatr Neurosci. 2013 May;8(2):117-9. (PMID: 24082928)
Neurobiol Dis. 2005 Nov;20(2):314-23. (PMID: 16242638)
Mol Cell Proteomics. 2013 Mar;12(3):825-31. (PMID: 23266961)
Database (Oxford). 2017 Jan 1;2017:. (PMID: 28605766)
Biochim Biophys Acta. 2009 Apr;1793(4):605-14. (PMID: 19046998)
Neuropediatrics. 2007 Feb;38(1):46-9. (PMID: 17607606)
Nucleic Acids Res. 1986 Jun 11;14(11):4683-90. (PMID: 3714490)
Mol Neurodegener. 2017 Jan 24;12(1):10. (PMID: 28118852)
J Biol Phys. 2009 Oct;35(4):317-36. (PMID: 19669420)
Zhonghua Er Ke Za Zhi. 2018 Aug 2;56(8):601-604. (PMID: 30078242)
Nature. 2005 May 5;435(7038):43-57. (PMID: 15875012)
Mol Syst Biol. 2007;3:89. (PMID: 17353931)
Science. 2009 Jul 24;325(5939):473-7. (PMID: 19556463)
Trends Mol Med. 2020 Jan;26(1):71-88. (PMID: 31791731)
J Cell Biol. 2017 Aug 7;216(8):2499-2513. (PMID: 28630145)
J Neurol Sci. 2020 Jul 15;414:116826. (PMID: 32302805)
Front Genet. 2020 Sep 02;11:536221. (PMID: 32983231)
Hum Genet. 1999 Jul-Aug;105(1-2):51-6. (PMID: 10480355)
Hum Genet. 2008 Jun;123(5):552. (PMID: 20960652)
J Neurosci. 2016 Aug 3;36(31):8238-49. (PMID: 27488642)
JIMD Rep. 2019 Sep 03;50(1):20-30. (PMID: 31741823)
Neurosci Lett. 2019 Apr 1;697:1-9. (PMID: 29626653)
Biochim Biophys Acta. 2013 Nov;1832(11):1807-26. (PMID: 23200925)
Sci Rep. 2017 May 9;7(1):1597. (PMID: 28487519)
Mol Cell Proteomics. 2006 Apr;5(4):686-701. (PMID: 16399764)
J Comp Neurol. 2000 Oct 23;426(3):406-12. (PMID: 10992246)
Hum Mol Genet. 2019 Oct 1;28(19):3309-3322. (PMID: 31294445)
Brain. 2015 Apr;138(Pt 4):862-74. (PMID: 25724202)
Brain Behav. 2015 Oct 09;5(11):e00401. (PMID: 26664787)
Int J Mol Sci. 2016 Dec 28;18(1):. (PMID: 28036022)
J Neuropathol Exp Neurol. 1997 Apr;56(4):369-75. (PMID: 9100667)
Int J Mol Sci. 2017 May 01;18(5):. (PMID: 28468312)
BMC Cell Biol. 2009 Nov 26;10:83. (PMID: 19941651)
Cytogenet Cell Genet. 1996;74(3):225-6. (PMID: 8941380)
Nat Rev Mol Cell Biol. 2004 Jul;5(7):554-65. (PMID: 15232573)
Neurology. 2010 Feb 16;74(7):565-71. (PMID: 20157158)
J Mol Biol. 2015 Nov 20;427(23):3722-33. (PMID: 26284972)
Exp Mol Pathol. 2014 Dec;97(3):484-91. (PMID: 25303899)
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D535-9. (PMID: 16381927)
Am J Hum Genet. 1994 Oct;55(4):695-701. (PMID: 7942847)
Biochim Biophys Acta Mol Cell Res. 2018 Jul 23;1865(10):1437-1450. (PMID: 30048658)
Hum Mutat. 2012 Jan;33(1):42-63. (PMID: 21990111)
J Cell Sci. 2017 Aug 1;130(15):2579-2590. (PMID: 28600323)
Biochim Biophys Acta. 2006 Oct;1762(10):865-72. (PMID: 16930952)
Nat Genet. 1998 Jul;19(3):286-8. (PMID: 9662406)
Neuropediatrics. 1991 May;22(2):92-6. (PMID: 1649978)
BMC Med Genet. 2020 May 11;21(1):100. (PMID: 32393339)
Neurology. 2005 Feb 22;64(4):740-2. (PMID: 15728307)
Dis Model Mech. 2017 Sep 1;10(9):1089-1100. (PMID: 28733362)
Neurobiol Dis. 2017 Apr;100:62-74. (PMID: 28065762)
Acta Neuropathol. 2019 Jan;137(1):71-88. (PMID: 30382371)
Cell. 2015 Jul 16;162(2):425-440. (PMID: 26186194)
Elife. 2017 Nov 14;6:. (PMID: 29135436)
N Z Vet J. 2002 Oct;50(5):199-202. (PMID: 16032271)
J Vet Intern Med. 2016 Jul;30(4):1149-58. (PMID: 27203721)
Hum Mol Genet. 2002 Apr 15;11(8):885-91. (PMID: 11971870)
Biochim Biophys Acta. 2015 Oct;1852(10 Pt B):2279-86. (PMID: 26073432)
Hum Mol Genet. 2011 Oct 1;20(19):3852-66. (PMID: 21752829)
Hum Gene Ther. 2011 Aug;22(8):1011-20. (PMID: 21595499)
PLoS One. 2013 Sep 10;8(9):e74299. (PMID: 24058541)
Neuromolecular Med. 2019 Jun;21(2):160-169. (PMID: 30919163)
Nature. 2013 Sep 19;501(7467):373-9. (PMID: 23995685)
Mol Cell Proteomics. 2006 Oct;5(10):1942-56. (PMID: 16709564)
Nat Cell Biol. 2006 Aug;8(8):843-8. (PMID: 16829952)
Autophagy. 2012 Jun;8(6):903-14. (PMID: 22576015)
Genomics. 1996 Jul 1;35(1):71-8. (PMID: 8661106)
Mol Cell. 2011 Oct 21;44(2):325-40. (PMID: 21906983)
Acta Neuropathol Commun. 2018 Aug 8;6(1):74. (PMID: 30089511)
Neurobiol Dis. 2014 Feb;62:543-50. (PMID: 24269732)
Nat Commun. 2017 Feb 06;8:14338. (PMID: 28165011)
Neurology. 2011 Apr 5;76(14):1245-51. (PMID: 21464428)
Neurology. 2000 Aug 22;55(4):579-81. (PMID: 10953198)
Cell Death Discov. 2020 Mar 30;6:18. (PMID: 32257390)
Cell Stem Cell. 2013 Aug 1;13(2):149-59. (PMID: 23910082)
PLoS One. 2013 Nov 01;8(11):e78694. (PMID: 24223841)
Nat Methods. 2013 Aug;10(8):730-6. (PMID: 23921808)
Hum Mol Genet. 2004 Dec 1;13(23):2893-906. (PMID: 15459177)
Biochim Biophys Acta. 2006 Oct;1762(10):890-7. (PMID: 16935476)
J Neuroinflammation. 2009 May 18;6:16. (PMID: 19450264)
Mol Genet Metab. 2015 Jun-Jul;115(2-3):101-9. (PMID: 25934231)
Mol Biol Cell. 2002 Jul;13(7):2410-20. (PMID: 12134079)
Neurobiol Dis. 2012 Apr;46(1):19-29. (PMID: 22182690)
Mol Cell Proteomics. 2011 Oct;10(10):M111.013284. (PMID: 21890473)
J Neurosci. 2008 Sep 3;28(36):8993-9001. (PMID: 18768693)
Mol Cell Biol. 2012 May;32(10):1855-66. (PMID: 22431521)
Acta Neuropathol Commun. 2017 Oct 17;5(1):74. (PMID: 29041969)
Brain Behav. 2018 Sep;8(9):e01096. (PMID: 30136763)
Sci Rep. 2019 Jan 17;9(1):151. (PMID: 30655561)
Exp Cell Res. 2017 Aug 1;357(1):40-50. (PMID: 28442266)
Hum Genet. 2008 Jun;123(5):554. (PMID: 20960661)
Mol Neurodegener. 2019 Jan 16;14(1):4. (PMID: 30651094)
Proteomics. 2005 Oct;5(15):3966-78. (PMID: 16145712)
Neurobiol Dis. 2004 Jun;16(1):29-40. (PMID: 15207259)
Neurosci Lett. 2018 Jun 21;678:8-15. (PMID: 29715546)
Front Genet. 2019 Apr 25;10:370. (PMID: 31105743)
Mol Genet Metab. 2019 May;127(1):107-115. (PMID: 31101435)
J Biol Chem. 2006 Feb 3;281(5):2784-94. (PMID: 16303764)
Biochim Biophys Acta. 2013 Nov;1832(11):1827-30. (PMID: 23542453)
Trends Neurosci. 2017 Jun;40(6):358-370. (PMID: 28527591)
Nat Struct Mol Biol. 2018 Jul;25(7):631-640. (PMID: 29967540)
Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18578-83. (PMID: 19011085)
J Child Neurol. 2018 Nov;33(13):837-850. (PMID: 30264640)
Neurobiol Dis. 2019 Feb;122:94-105. (PMID: 29859318)
Biochim Biophys Acta Mol Basis Dis. 2020 Sep 1;1866(9):165614. (PMID: 31783156)
Mol Cell Biol. 2018 Sep 28;38(20):. (PMID: 30037983)
Acta Neuropathol Commun. 2019 Dec 30;7(1):222. (PMID: 31888773)
Pediatr Neurol. 1992 Mar-Apr;8(2):121-6. (PMID: 1580955)
Cell. 2010 May 28;141(5):897-907. (PMID: 20510933)
Nat Rev Mol Cell Biol. 2003 Mar;4(3):202-12. (PMID: 12612639)
Hum Mutat. 2013 Dec;34(12):1688-97. (PMID: 24038957)
Genome Biol. 2013 Apr 29;14(4):R37. (PMID: 23628362)
Cell Signal. 2020 Jun;70:109572. (PMID: 32087303)
Brain Pathol. 2004 Oct;14(4):349-57. (PMID: 15605981)
Neurobiol Dis. 2008 Feb;29(2):306-15. (PMID: 17988881)
Mol Genet Metab. 2006 Nov;89(3):245-53. (PMID: 16814585)
Metallomics. 2014 Apr;6(4):932-43. (PMID: 24804307)
BMC Neurosci. 2004 May 21;5:19. (PMID: 15153250)
Front Cell Dev Biol. 2017 Dec 12;5:110. (PMID: 29312935)
Genesis. 2015 Aug;53(8):523-534. (PMID: 26088819)
Exp Eye Res. 2008 Dec;87(6):529-34. (PMID: 18834879)
Electrophoresis. 2012 Dec;33(24):3798-809. (PMID: 23160995)
Dev Med Child Neurol. 2017 Aug;59(8):815-821. (PMID: 28542837)
Eur J Biochem. 2001 Nov;268(22):5851-6. (PMID: 11722572)
Cold Spring Harb Perspect Biol. 2014 Feb 01;6(2):. (PMID: 24492709)
Hum Mol Genet. 2014 Jun 1;23(11):2802-15. (PMID: 24399444)
Genomics. 2005 Sep;86(3):287-94. (PMID: 16033706)
J Inherit Metab Dis. 1993;16(2):230-2. (PMID: 8411967)
BMC Med Genet. 2012 Jun 24;13:50. (PMID: 22727047)
J Neurol. 2015 Jan;262(1):173-8. (PMID: 25359263)
Front Hum Neurosci. 2014 Jul 11;8:501. (PMID: 25071529)
J Child Neurol. 2011 May;26(5):625-9. (PMID: 21447811)
Brain. 2009 Mar;132(Pt 3):810-9. (PMID: 19201763)
J Neurosci. 2012 Sep 19;32(38):13200-5. (PMID: 22993436)
Nature. 2008 Sep 4;455(7209):64-71. (PMID: 18668037)
Nature. 2017 May 25;545(7655):505-509. (PMID: 28514442)
Neurobiol Dis. 2009 May;34(2):308-19. (PMID: 19385065)
Neuropediatrics. 1982 Aug;13(3):135-41. (PMID: 7133332)
J Proteome Res. 2013 May 3;12(5):2101-15. (PMID: 23464991)
J Biomed Sci. 2016 Nov 24;23(1):83. (PMID: 27881166)
Exp Cell Res. 2015 Oct 15;338(1):45-53. (PMID: 26342652)
Lancet Neurol. 2019 Apr;18(4):406-414. (PMID: 30795987)
Nat Protoc. 2007;2(6):1307-16. (PMID: 17545967)
Biochim Biophys Acta. 2015 Oct;1852(10 Pt B):2262-6. (PMID: 25989315)
ScientificWorldJournal. 2012;2012:383174. (PMID: 22919312)
Hum Mutat. 2009 May;30(5):E651-61. (PMID: 19309691)
Clin Genet. 2008 Sep;74(3):213-22. (PMID: 18684116)
Cell. 2019 Sep 19;179(1):147-164.e20. (PMID: 31539493)
J Clin Invest. 2008 Sep;118(9):3075-86. (PMID: 18704195)
Hum Mutat. 2010 Mar;31(3):356-65. (PMID: 20052765)
Cell Mol Life Sci. 2011 Feb;68(3):453-74. (PMID: 20680390)
Biochim Biophys Acta Mol Basis Dis. 2017 Jun;1863(6):1273-1281. (PMID: 28390949)
فهرسة مساهمة: Keywords: Batten disease; CLN5; Lysosome; Neurodegeneration; Neuronal ceroid lipofuscinosis
المشرفين على المادة: 0 (CLN5 protein, human)
0 (Cln5 protein, mouse)
0 (Lysosomal Membrane Proteins)
تواريخ الأحداث: Date Created: 20210401 Date Completed: 20210621 Latest Revision: 20240121
رمز التحديث: 20240121
مُعرف محوري في PubMed: PMC8195759
DOI: 10.1007/s00018-021-03813-x
PMID: 33792748
قاعدة البيانات: MEDLINE
الوصف
تدمد:1420-9071
DOI:10.1007/s00018-021-03813-x